The North America travel vaccines market is expected to grow from US$ 1,276.32 million in 2021 to US$ 2,503.59 million by 2028; it is estimated to grow at a CAGR of 10.1% from 2021 to 2028.

North America Travel Vaccines Market Introduction

For many, travel and tourism have become an intrinsic part of life. They offer not just a change of pace, but also invaluable opportunities to discover different cultures, traditions, spiritualism, rural and ethnic tourism, and wellness holidays globally. When traveling internationally, immunization is a vital precautionary measure to prevent the spread of infections. Many countries have implemented policies to protect their populations from travel-associated illnesses. Estimates indicate that travel and tourism will continue to expand in the years ahead. This growth, combined with economic pressures and the demand for better job opportunities, is driving the need for travel vaccines.

The advent of new features and technologies allows vendors to attract fresh customers and broaden their market footprint in developing regions. This factor is expected to propel the North America travel vaccines market, which is projected to achieve a good CAGR over the forecast period.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/BMIRE00025499

North America Travel Vaccines Strategic Insights

Strategic insights for the North America Travel Vaccines market deliver a data-backed examination of the industry environment, encompassing current trends, key players, and regional specificities. These insights provide practical advice, enabling readers to distinguish themselves from rivals by pinpointing unaddressed market segments or crafting compelling value propositions. Utilizing data analytics, these insights assist industry players in anticipating market shifts, regardless of whether they are investors, manufacturers, or other stakeholders. A forward-looking viewpoint is crucial, helping stakeholders foresee market changes and strategically prepare for enduring success in this lively region. Ultimately, potent strategic insights empower readers to make well-informed decisions that enhance profitability and aid in achieving their business goals within the market.

North America Travel Vaccines Market Segmentation

North America Travel Vaccines Market By Product

Hepatitis A

Hepatitis B

Meningococcal Vaccines

North America Travel Vaccines Market By Application

Domestic Travel and Outbound Travel

North America Travel Vaccines Market Regions and Countries Covered  

North America

US

Canada

Mexico

North America Travel Vaccines Market leaders and key company profiles          

Abbott

Dynavax Technologies

Emergent BioSolutions Inc.

GlaxoSmithKline plc

Merck & Co., Inc.

Novartis AG

Pfizer Inc.

Sanofi

Valneva SE.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications